TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
126,318
|
149,969
|
124,300 |
| Financial expenses |
273
|
2
|
7 |
| Earnings before taxes |
2,798
|
26,296
|
24,650 |
| EBITDA |
6,055
|
30,452
|
27,517 |
| Total assets |
253,226
|
110,324
|
78,830 |
| Current assets |
173,904
|
80,341
|
47,164 |
| Current liabilities |
140,805
|
39,567
|
33,428 |
| Equity capital |
110,774
|
69,310
|
45,403 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.7%
|
62.8%
|
57.6% |
| Turnover per employee |
25,264
|
37,492
|
41,433 |
| Profit as a percentage of turnover |
2.2%
|
17.5%
|
19.8% |
| Return on assets (ROA) |
1.2%
|
23.8%
|
31.3% |
| Current ratio |
123.5%
|
203.1%
|
141.1% |
| Return on equity (ROE) |
2.5%
|
37.9%
|
54.3% |
| Change turnover |
-26,355
|
16,849
|
65,818 |
| Change turnover % |
-17%
|
13%
|
113% |
| Chg. No. of employees |
1
|
1
|
3 |
| Chg. No. of employees % |
25%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.